Intentionally unilateral prostatic artery embolization: Patient selection, technique and potential benefits

Table 1 Baseline demographic, anatomic and clinical data of the two patient groups in this study (intentionally unilateral prostatic artery embolization group vs control)

	IU-PAE (n = 13)	Control (n = 30)	P value
Age (mean ± SD, years)	76.5 ± 8.2	71.8 ± 10.6	0.166
BMI (mean ± SD, kg/m2)	28.7 ± 4.6	27.0 ± 2.8	0.300
PV (mean ± SD, mL)	106.7 ± 43.8	92.8 ± 27.1	0.330
Grade of tortuosity (mean ± SD)	2.2 ± 0.9	2.1 ± 0.8	0.736
Grade of atheroma (mean ± SD)	1.5 ± 0.7	1.2 ± 0.6	0.360
LUTS, proportion of pts	9/13	22/30	0.779
IPSS (mean ± SD)	26.0 ± 4.0	26.5 ± 3.9	0.708
IBC proportion of pts	4/13	8/30	0.779

IU-PAE: Intentionally unilateral prostatic artery embolization; BMI: Body mass index; PV: Prostate volume; LUTS: Lower urinary tract symptoms; IPSS: International prostate symptom score; IBC: Indwelling bladder catheter.